Flow Traders U.S.’s Takeda Pharmaceutical TAK Stock Holding History

Flow Traders U.S.’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Buy	+13,484	New	+$223K	0.01%	883
2026 Q1	–	Sell	-20,725	Closed	-$323K	–	1286
2025 Q4	$323K	Buy	+20,725	New	+$296K	0.01%	680
2024 Q2	–	Sell	-12,245	Closed	-$170K	–	1079
2024 Q1	$170K	Buy	+12,245	New	+$178K	0.01%	665
2023 Q4	–	Sell	-139,769	Closed	-$2.16M	–	1094
2023 Q3	$2.16M	Buy	139,769 +90,266	+182%	+$1.4M	0.1%	185
2023 Q2	$778K	Buy	+49,503	New	+$811K	0.03%	393

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Flow Traders U.S.'s TAK Position: Q2 2026 in Review

Flow Traders U.S. opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 13,484 shares worth $216K. The stake represents 0.01% of the portfolio and ranks #883 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in TAK as recently as Q4 2025.

Flow Traders U.S. first reported a position in TAK in Q2 2023 and has held it in 5 quarters since. The position peaked at $2.16M in Q3 2023. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Flow Traders U.S. held 13,484 shares of Takeda Pharmaceutical worth $216K as of Q2 2026.
Takeda Pharmaceutical was a new Flow Traders U.S. position in Q2 2026.
Takeda Pharmaceutical made up 0.01% of Flow Traders U.S.'s portfolio in Q2 2026, its #883 holding.
Flow Traders U.S. first reported a position in Takeda Pharmaceutical in Q2 2023 and has held it in 5 quarters since.
Flow Traders U.S.'s Takeda Pharmaceutical position peaked at $2.16M in Q3 2023.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.